MEDICAL HUMAN FACTORS LTD

Company Registration Number:
09488011 (England and Wales)

Unaudited abridged accounts for the year ended 31 December 2025

Period of accounts

Start date: 01 January 2025

End date: 31 December 2025

MEDICAL HUMAN FACTORS LTD

Contents of the Financial Statements

for the Period Ended 31 December 2025

Balance sheet
Notes

MEDICAL HUMAN FACTORS LTD

Balance sheet

As at 31 December 2025


Notes

2025

2024


£

£
Fixed assets
Tangible assets: 3 15,466 12,821
Total fixed assets: 15,466 12,821
Current assets
Debtors:   53,405 49,476
Cash at bank and in hand: 782,182 549,104
Total current assets: 835,587 598,580
Creditors: amounts falling due within one year:   (162,454) (170,304)
Net current assets (liabilities): 673,133 428,276
Total assets less current liabilities: 688,599 441,097
Total net assets (liabilities): 688,599 441,097
Capital and reserves
Called up share capital: 100 100
Profit and loss account: 688,499 440,997
Shareholders funds: 688,599 441,097

The notes form part of these financial statements

MEDICAL HUMAN FACTORS LTD

Balance sheet statements

For the year ending 31 December 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 23 September 2026
and signed on behalf of the board by:

Name: Lee Wood
Status: Director

The notes form part of these financial statements

MEDICAL HUMAN FACTORS LTD

Notes to the Financial Statements

for the Period Ended 31 December 2025

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

Turnover policy

Turnover Turnover comprises the invoice value of goods supplied by the company, exclusive of trade discounts and value added tax.

Tangible fixed assets and depreciation policy

PROPERTY, PLANT AND EQUIPMENT AND DEPRECIATION Property, plant and equipment are stated at cost or at valuation, less accumulated depreciation. Cost comprises purchase price and other directly attributable costs. The charge to depreciation is calculated to write off the original cost or valuation of property, plant and equipment, less their estimated residual value, over their expected useful lives as follows: - Fixtures, fittings and equipment at 25% straight line. The carrying values of tangible fixed assets are reviewed annually for impairment in periods if events or changes in circumstances indicate the carrying value may not be recoverable.

Other accounting policies

STATEMENT OF COMPLIANCE The financial statements of the company for the financial year ended 31 December 2025 have been prepared in accordance with the provisions of FRS 102 Section 1A (Small Entities) and the Companies Act 2006. BASIS OF PREPARATION The financial statements have been prepared on the going concern basis and in accordance with the historical cost convention except for certain properties and financial instruments that are measured at revalued amounts or fair values, as explained in the accounting policies below. Historical cost is generally based on the fair value of the consideration given in exchange for assets. TRADE AND OTHER CREDITORS Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost. EMPLOYEE BENEFITS The company operates a defined contribution pension scheme. The assets of the scheme are held separately from those of the company in an independently administered fund. The company also operates a defined benefit pension scheme for its employees providing benefits based on final pensionable pay. The assets of this scheme are also held separately from those of the company, being invested with pension fund managers. TAXATION AND DEFERRED TAXATION Current tax represents the amount expected to be paid or recovered in respect of taxable profits for the financial year and is calculated using the tax rates and laws that have been enacted or substantially enacted at the Statement of Financial Position date. Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date where transactions or events have occurred at that date that will result in an obligation to pay more tax in the future, or a right to pay less tax in the future. Timing differences are temporary differences between the company's taxable profits and its results as stated in the financial statements. Deferred tax is measured on an undiscounted basis at the tax rates that are anticipated to apply in the periods in which the timing differences are expected to reverse, based on tax rates and laws that have been enacted or substantively enacted by the Statement of Financial Position date. FOREIGN CURRENCIES Monetary assets and liabilities denominated in foreign currencies are translated at the rates of exchange ruling at the Statement of Financial Position date. Non-monetary items that are measured in terms of historical cost in a foreign currency are translated at the rates of exchange ruling at the date of the transaction. Non-monetary items that are measured at fair value in a foreign currency are translated using the exchange rates at the date when the fair value was determined. The resulting exchange differences are dealt with in the Income Statement. ORDINARY SHARE CAPITAL The ordinary share capital of the company is presented as equity.

MEDICAL HUMAN FACTORS LTD

Notes to the Financial Statements

for the Period Ended 31 December 2025

2. Employees

2025 2024
Average number of employees during the period 15 15

MEDICAL HUMAN FACTORS LTD

Notes to the Financial Statements

for the Period Ended 31 December 2025

3. Tangible Assets

Total
Cost £
At 01 January 2025 35,887
Additions 6,604
At 31 December 2025 42,491
Depreciation
At 01 January 2025 23,066
Charge for year 3,959
At 31 December 2025 27,025
Net book value
At 31 December 2025 15,466
At 31 December 2024 12,821